© 2020 Cellular Engineering Technologies.

Human Amniotic Membrane Mesenchymal Stem Cell

 

This iPS cell line was created using a normal amniotic-derived mesenchymal stem cell (Am-MSC). The iPS cell line was created using an episomal proprietary mix of vectors (containing Oct-4, Sox-2, Klf-4 along with p53 Anti-sense, EBNA-1) necessary to reprogram Am-MSC into induced pluripotent stem cells (iPSC). The cell line was validated for pluripotency based on colony morphology, alkaline phosphatase expression, and expression of SSEA-4. Cells are free of Mycoplasma. iPS colonies exhibit classical morphology and growth. Cell line is shipped on dry ice.

Media Usage Protocol (includes quality control flow cytometry data): Human Amniotic Membrane Mesenchymal Stem Cell Induced Pluripotent Stem Cells Protocol.pdf